Department of Biotechnology (DBT)

The Department of Biotechnology (DBT) is a department under the Ministry of Science and Technology, Government of India, established in 1986. It is the nodal agency for planning, promoting, and coordinating biotechnology-related programs and activities across the country. Located at CGO Complex, Lodhi Road, New Delhi, DBT funds research institutions, universities, and industry partners while also setting the regulatory and policy framework for biotechnology in India.

DBT oversees a network of autonomous institutions, public sector undertakings, and interface agencies including BIRAC, which serves as its primary arm for startup and industry engagement.

Role in the Startup Ecosystem

DBT is the upstream policy and funding body that shapes India's entire biotech innovation landscape. While BIRAC handles direct startup engagement, DBT sets the strategic direction, allocates budgets, designs national programs, and coordinates with international partners. Its role extends beyond startups to encompass basic research, regulatory frameworks, and human resource development in biotechnology. For the startup ecosystem, DBT's most important contributions are the creation and funding of BIRAC, the BioNEST incubator network, and sector-specific programs that channel research into commercializable products.

Programs and Initiatives

DBT runs and funds several key programs relevant to startups. The Biotechnology Ignition Grant (BIG) and other BIRAC-administered schemes are funded by DBT. The BioNEST program creates bio-incubation centres at universities and research institutions across India. The E-YUVA program promotes student entrepreneurship in biotechnology. DBT also runs the Biotechnology Industry Partnership Programme (BIPP) for industry-academia collaboration, the BioE3 Policy for biomanufacturing, and joint calls with BIRAC for emerging areas like Bio-AI. DBT's international collaborations bring global partnerships and funding opportunities to Indian biotech ventures.

Who Benefits

Biotech researchers, academic institutions setting up incubators, and startups at all stages working in healthcare, agriculture, environmental biotechnology, and industrial biotech. DBT programs particularly benefit institutions seeking to create bio-incubation infrastructure and researchers looking for translational research funding.

Strategic Impact

DBT has been the architect of India's biotech growth story, taking the sector from a nascent industry in the 1980s to a $130+ billion industry today. Its creation of BIRAC in 2012 was a turning point for biotech entrepreneurship in India, and its continued investment in incubation infrastructure, research funding, and international partnerships ensures a steady pipeline of biotech innovations from lab to market.